https://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-antiviral-treatment-covid-19-adults
0
0
5/25/23 at 1:00pm
Organization
FDA.gov
Author
Office of the Commissioner
The FDA approved Paxlovid for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19.
Create an account
or login to join the discussion